TY - JOUR
T1 - Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates
AU - Allaham, Kholoud K.
AU - Feyasa, Merga Belina
AU - Govender, Romona Devi
AU - Musa, Anas Mahmoud Abbas
AU - Alkaabi, Ahmed Juma
AU - Elbarazi, Iffat
AU - Alsheryani, Shamma Dahi
AU - Falasi, Reem Juma Al
AU - Khan, Moien Ab
N1 - Funding Information:
The study was supported by the United Arab Emirates University Research Grant (Grant Code – G0000356/12M090-NP-21-13). The funder did not have a role in the design, collection, analysis, interpretation of data, and/or writing of this manuscript.
Publisher Copyright:
© 2022 Allaham et al.
PY - 2022
Y1 - 2022
N2 - Background: Multimorbidity, defined as having two or more chronic diseases, has a major impact on public health and Sustainable Development Goals (SDG). This study aims to assess the prevalence of medication adherence and associated factors among patients with multimorbidity. Methods: A questionnaire-based, cross-sectional survey was conducted by a trained interviewer across patients with multimorbidity attending outpatient clinics in two tertiary referral hospitals in the United Arab Emirates (UAE). Demographic and social variables and the outcome (self-reported adherence to long-term medication) were measured using the General Medication Adherence Scale (GMAS). Multiple logistic regression was used to assess medication adherence and associated factors. Results: From a total of 630 participants included in this study, the estimated prevalence of high medication adherence is 78.57% (±1.63478) with a 95% confidence interval (CI) [75.19, 81.61]. The odds of high medication adherence increased with age. The odds of high medication adherence for patients aged 66 years and older than those aged 19–35 years is adjusted odds ratio (AOR) = 3.880, with a 95% CI [1.124, 13.390]. Patients with income more than 50,000 had the odds, AOR = 5.169 with a 95% CI [1.282, 20.843], compared to those earning less than 10,000 Dirhams (AED). Patients aged 36–65 with health insurance coverage had higher medication adherence than groups on the other end. The number of current medications is significantly (p-value = 0.027) associated with high medication adherence with the odds of high medication adherence, AOR = 4.529 with a 95% CI [1.184, 17.326], the highest for those currently taking four medications. Conclusion: This study highlights younger population having multimorbidity in the context of an increasing life expectancy and suboptimal therapeutic outcomes. Furthermore, the study highlights multimorbidity is associated with low medication adherence and out-of-pocket payment, and non-availability of insurance is a major hindrance to medication adherence.
AB - Background: Multimorbidity, defined as having two or more chronic diseases, has a major impact on public health and Sustainable Development Goals (SDG). This study aims to assess the prevalence of medication adherence and associated factors among patients with multimorbidity. Methods: A questionnaire-based, cross-sectional survey was conducted by a trained interviewer across patients with multimorbidity attending outpatient clinics in two tertiary referral hospitals in the United Arab Emirates (UAE). Demographic and social variables and the outcome (self-reported adherence to long-term medication) were measured using the General Medication Adherence Scale (GMAS). Multiple logistic regression was used to assess medication adherence and associated factors. Results: From a total of 630 participants included in this study, the estimated prevalence of high medication adherence is 78.57% (±1.63478) with a 95% confidence interval (CI) [75.19, 81.61]. The odds of high medication adherence increased with age. The odds of high medication adherence for patients aged 66 years and older than those aged 19–35 years is adjusted odds ratio (AOR) = 3.880, with a 95% CI [1.124, 13.390]. Patients with income more than 50,000 had the odds, AOR = 5.169 with a 95% CI [1.282, 20.843], compared to those earning less than 10,000 Dirhams (AED). Patients aged 36–65 with health insurance coverage had higher medication adherence than groups on the other end. The number of current medications is significantly (p-value = 0.027) associated with high medication adherence with the odds of high medication adherence, AOR = 4.529 with a 95% CI [1.184, 17.326], the highest for those currently taking four medications. Conclusion: This study highlights younger population having multimorbidity in the context of an increasing life expectancy and suboptimal therapeutic outcomes. Furthermore, the study highlights multimorbidity is associated with low medication adherence and out-of-pocket payment, and non-availability of insurance is a major hindrance to medication adherence.
KW - Global burden of disease
KW - Medication adherence
KW - Multimorbidity
KW - Sustainable development goals
KW - United Arab Emirates
UR - http://www.scopus.com/inward/record.url?scp=85133462256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133462256&partnerID=8YFLogxK
U2 - 10.2147/PPA.S355891
DO - 10.2147/PPA.S355891
M3 - Article
AN - SCOPUS:85133462256
SN - 1177-889X
VL - 16
SP - 1187
EP - 1200
JO - Patient Preference and Adherence
JF - Patient Preference and Adherence
ER -